Nathan Clumeck

Medicine · Health Sciences

65h-index21.0kcitations564works20.22yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(170), HIV Research and Treatment(148), HIV/AIDS Research and Interventions(119), Pneumocystis jirovecii pneumonia detection and treatment(73), HIV-related health complications and treatments(56)

Publications549 total

Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe
JHEP Reports·2025· 1 citedOpen Access
Observational cohort study of rilpivirine (RPV) utilization in Europe
AIDS Research and Therapy·2022· 5 citedOpen Access
Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons
Open Forum Infectious Diseases·2020· 2 citedOpen Access
Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff
Journal of Hospital Infection·2020· 104 citedOpen Access
Treatment of Toxoplasmic Encephalitis in Patients with AIDS
Annals of Internal Medicine·2020
Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases
The International Journal of Tuberculosis and Lung Disease·2018· 23 cited
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
The Lancet HIV·2017· 35 citedOpen Access
Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB Strategy
Epidemiology and Infection·2017· 1 citedOpen Access
Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors
Scientific Reports·2016· 11 citedOpen Access
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study
The Lancet Infectious Diseases·2016· 66 citedOpen Access
List of Contributors
Infectious Diseases·2016
Opportunistic Infections
Infectious Diseases·2016· 3 cited
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor–based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials
Clinical Infectious Diseases·2016· 16 citedOpen Access
Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line
Scientific Reports·2016· 41 citedOpen Access
Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a cross-sectional study
Sexually Transmitted Infections·2016· 25 cited
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial
The Lancet HIV·2016· 165 cited
Brief Report
JAIDS Journal of Acquired Immune Deficiency Syndromes·2016· 178 citedOpen Access
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
The Lancet Infectious Diseases·2016· 274 citedOpen Access
Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates <scp>HIV</scp> ‐1
EMBO Molecular Medicine·2015· 85 citedOpen Access
Sequential treatment with 5-aza-2′deoxycitidine and deacetylase inhibitors reactivates HIV
Journal of Virus Eradication·2015Open Access
page 1 of 28Next →

Frequent Co-authors

Jens Lundgren(11), Amanda Mocroft(6), Bonaventura Clotet(5), Christine Katlama(5), Adriano Lazzarin(5), Francisco Antunes(5), Kabamba Kabeya(5), Philippe Van de Perre(4), José Ramón Arribas(4), Olivier Rohr(4), Carine Van Lint(4), Andrew Phillips(4), Mark Nelson(3), James Goodrich(3), Edwin DeJesus(3), Elna van der Ryst(3), Howard Mayer(3), François Raffi(3), Sophie Bouchat(3), Caroline Vanhulle(3)